Spenta International Limited (BOM:526161)
106.15
-2.50 (-2.30%)
At close: Jul 29, 2025
CTI BioPharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 110.84 | 9.65 | 5.32 | 4.4 | 2.48 | Upgrade |
Short-Term Investments | 12.31 | 98.99 | 63.58 | 53.96 | 51.76 | Upgrade |
Cash & Short-Term Investments | 123.15 | 108.64 | 68.91 | 58.37 | 54.23 | Upgrade |
Cash Growth | 13.36% | 57.66% | 18.06% | 7.62% | 8.62% | Upgrade |
Accounts Receivable | 115.68 | 105.18 | 129.04 | 159.12 | 145.01 | Upgrade |
Other Receivables | 19.54 | 26.35 | 25.63 | 22.94 | 14.33 | Upgrade |
Receivables | 136.95 | 133.55 | 157.52 | 184.42 | 161.48 | Upgrade |
Inventory | 152.74 | 148.16 | 145.96 | 147.72 | 97.75 | Upgrade |
Prepaid Expenses | - | 1.48 | 1.47 | 2.09 | 1.22 | Upgrade |
Other Current Assets | 8.81 | 10.24 | 13.46 | 10.57 | 7.16 | Upgrade |
Total Current Assets | 421.65 | 402.07 | 387.31 | 403.17 | 321.85 | Upgrade |
Property, Plant & Equipment | 138.07 | 145.49 | 154.9 | 164.7 | 173.89 | Upgrade |
Long-Term Deferred Tax Assets | 2.27 | 1.65 | 0.8 | -0.1 | 0.81 | Upgrade |
Long-Term Deferred Charges | - | - | - | 3.41 | - | Upgrade |
Other Long-Term Assets | 14.89 | 14.89 | 14.69 | 13.69 | 19.01 | Upgrade |
Total Assets | 581.21 | 566.04 | 559.65 | 588.96 | 518.7 | Upgrade |
Accounts Payable | 26.44 | 15.04 | 30.08 | 55.59 | 40.08 | Upgrade |
Accrued Expenses | 1.93 | 10.06 | 10.84 | 9.68 | 7.82 | Upgrade |
Short-Term Debt | - | 184.27 | 148.4 | 140.31 | 113.26 | Upgrade |
Current Portion of Long-Term Debt | 192.1 | - | - | - | - | Upgrade |
Current Income Taxes Payable | 1.98 | 1.38 | 0.49 | - | - | Upgrade |
Current Unearned Revenue | - | 4 | 3.32 | 1.13 | 1.65 | Upgrade |
Other Current Liabilities | 19.86 | 12.98 | 24.51 | 35.42 | 22.65 | Upgrade |
Total Current Liabilities | 242.3 | 227.73 | 217.64 | 242.14 | 185.46 | Upgrade |
Long-Term Debt | 31.09 | 40.55 | 55.94 | 69.68 | 78.2 | Upgrade |
Other Long-Term Liabilities | 17.12 | - | -0 | - | - | Upgrade |
Total Liabilities | 290.51 | 285.16 | 286.17 | 322.77 | 275.5 | Upgrade |
Common Stock | 27.64 | 27.64 | 27.64 | 27.64 | 27.64 | Upgrade |
Retained Earnings | - | 255.04 | 246.76 | 239.37 | 217.07 | Upgrade |
Comprehensive Income & Other | 263.05 | -1.8 | -0.92 | -0.82 | -1.51 | Upgrade |
Shareholders' Equity | 290.69 | 280.89 | 273.48 | 266.19 | 243.2 | Upgrade |
Total Liabilities & Equity | 581.21 | 566.04 | 559.65 | 588.96 | 518.7 | Upgrade |
Total Debt | 223.19 | 224.82 | 204.33 | 209.99 | 191.46 | Upgrade |
Net Cash (Debt) | -100.04 | -116.18 | -135.43 | -151.62 | -137.23 | Upgrade |
Net Cash Per Share | -36.15 | -42.03 | -48.99 | -54.85 | -49.64 | Upgrade |
Filing Date Shares Outstanding | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 | Upgrade |
Total Common Shares Outstanding | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 | Upgrade |
Working Capital | 179.35 | 174.34 | 169.68 | 161.03 | 136.39 | Upgrade |
Book Value Per Share | 105.18 | 101.61 | 98.93 | 96.30 | 87.98 | Upgrade |
Tangible Book Value | 290.69 | 280.89 | 273.48 | 266.19 | 243.2 | Upgrade |
Tangible Book Value Per Share | 105.18 | 101.61 | 98.93 | 96.30 | 87.98 | Upgrade |
Land | - | 6.24 | 6.24 | 6.24 | 6.24 | Upgrade |
Buildings | - | 141.31 | 141.31 | 141.31 | 141.31 | Upgrade |
Machinery | - | 70.62 | 70.54 | 69.53 | 69.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.